FRONTLINE COMBO PACK CONSULT SPOT ON DOG XL
Country: Netherlands
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
07-06-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
fipronil 402 mg, methoprene 361.8 mg
Available from:
MERIAL SAS
ATC code:
QP53AX65
Pharmaceutical form:
Spot-on solution
Therapeutic group:
Fipronil, combinations
Therapeutic area:
Dogs
Authorization date:
2012-09-26
Summary of Product characteristics
Frontline Combo Pack Consult Spot on Dog XL
eu-frontline-combo-dog-xl-201208-pi-a
1
SUMMARY OF PRODUCT CHARACTERISTICS
Frontline Combo Pack Consult Spot on Dog XL
eu-frontline-combo-dog-xl-201208-pi-a
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
FRONTLINE COMBO PACK CONSULT PACK CONSULT SPOT-ON DOG XL
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 4.02 ml contains:
Fipronil ................................................................................................................... 402.00 mg
(S)-methoprene ....................................................................................................... 361.80 mg
Butylhydroxyanisole (E320) ........................................................................................ 0.80 mg
Butylhydroxytoluene (E321) ........................................................................................ 0.40 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing over 40 kg bodyweight:
- To be used against infestations with fleas, alone or in association with ticks and/or biting lice.
- Treatment of flea infestations (_Ctenocephalides_ spp.). Insecticidal efficacy against new
infestations with adult fleas persists for 8 weeks. Prevention of the multiplication of fleas by inhibiting
the development of eggs (ovicidal activity) and larvae and pupae (larvicidal activity) originating from
eggs laid by adult fleas for eight weeks after application.
- Treatment of tick infestations (_Ixodes_ _ricinus_, _Dermacentor_ _variabilis, Dermacentor re
Read the complete document
